Search

Your search keyword '"RIPK2"' showing total 310 results

Search Constraints

Start Over You searched for: Descriptor "RIPK2" Remove constraint Descriptor: "RIPK2"
310 results on '"RIPK2"'

Search Results

1. YOD1 sustains NOD2-mediated protective signaling in colitis by stabilizing RIPK2.

2. Deubiquitination of RIPK2 by OTUB2 augments NOD2 signalling and protective effects in intestinal inflammation.

3. Ripks and Neuroinflammation.

4. Expression of Truncated Products at the 5′-Terminal Region of RIPK2 and Evolutive Aspects that Support Their Biological Importance.

5. Deubiquitination of RIPK2 by OTUB2 augments NOD2 signalling and protective effects in intestinal inflammation

7. RIPK2 and lysosomal pathway: Unveiling a new mechanism for lung cancer metastasis

8. Enterococcus faecalis Extracellular Vesicles Promote Apical Periodontitis.

9. Methynissolin confers protection against gastric carcinoma via targeting RIPK2

10. Receptor-interacting protein kinase 2 (RIPK2) profoundly contributes to post-stroke neuroinflammation and behavioral deficits with microglia as unique perpetrators

11. NOD1 cooperates with HAX‐1 to promote cell migration in a RIPK2‐ and NF‐ĸB‐independent manner.

12. Receptor-interacting protein kinase 2 (RIPK2) profoundly contributes to post-stroke neuroinflammation and behavioral deficits with microglia as unique perpetrators.

13. RIPK2: a promising target for cancer treatment.

15. Novel Biomarkers for Inflammatory Bowel Disease and Colorectal Cancer: An Interplay between Metabolic Dysregulation and Excessive Inflammation.

16. Recent advances in the development of RIPK2 modulators for the treatment of inflammatory diseases.

17. Identification and expression profiling of receptor‐interacting serine/threonine‐protein kinase 2 in Siberian sturgeon (Acipenser baerii).

18. Pan-cancer analysis reveals RIPK2 predicts prognosis and promotes immune therapy resistance via triggering cytotoxic T lymphocytes dysfunction

19. A pancancer analysis of the carcinogenic role of receptor-interacting serine/threonine protein kinase-2 (RIPK2) in human tumours

20. High expression of RIPK2 is associated with Taxol resistance in serous ovarian cancer

21. Insights into molecular characterization of NOD1-RIPK interaction and transcriptional modulation in response to LPS in spotted snakehead, Channa punctata (Bloch, 1793).

22. Recent advances in the development of RIPK2 modulators for the treatment of inflammatory diseases

23. Transcriptome alterations in chicken HD11 cells with steady knockdown and overexpression of RIPK2 gene

24. NOD-like receptors in asthma.

26. NOD-like receptors in asthma

27. Methynissolin confers protection against gastric carcinoma via targeting RIPK2.

28. Pharmacological inhibition of receptor-interacting protein kinase 2 (RIPK2) elicits neuroprotective effects following experimental ischemic stroke.

29. XIAP promotes melanoma growth by inducing tumour neutrophil infiltration.

30. Pan-cancer analysis reveals RIPK2 predicts prognosis and promotes immune therapy resistance via triggering cytotoxic T lymphocytes dysfunction.

31. A pancancer analysis of the carcinogenic role of receptor-interacting serine/threonine protein kinase-2 (RIPK2) in human tumours.

32. High expression of RIPK2 is associated with Taxol resistance in serous ovarian cancer.

33. Fusobacterium nucleatum promotes esophageal squamous cell carcinoma progression via the NOD1/RIPK2/NF-κB pathway.

34. RIPK2 and lysosomal pathway: Unveiling a new mechanism for lung cancer metastasis.

35. The potent and selective RIPK2 inhibitor BI 706039 improves intestinal inflammation in the TRUC mouse model of inflammatory bowel disease.

36. Receptor‐interacting protein kinase 2 contributes to host innate immune responses against Fusobacterium nucleatum in macrophages and decidual stromal cells.

37. Receptor-Interacting Serine/Threonine-Protein Kinase-2 as a Potential Prognostic Factor in Colorectal Cancer.

38. RIPK2 as a New Therapeutic Target in Inflammatory Bowel Diseases

39. microRNA-210 and microRNA-3570 Negatively Regulate NF-κB-Mediated Inflammatory Responses by Targeting RIPK2 in Teleost Fish

40. Knockdown of RIPK2 Inhibits Proliferation and Migration, and Induces Apoptosis via the NF-κB Signaling Pathway in Gastric Cancer

41. microRNA-210 and microRNA-3570 Negatively Regulate NF-κB-Mediated Inflammatory Responses by Targeting RIPK2 in Teleost Fish.

42. Knockdown of RIPK2 Inhibits Proliferation and Migration, and Induces Apoptosis via the NF-κB Signaling Pathway in Gastric Cancer.

43. RIPK2 NODs to XIAP and IBD.

44. RIPK protein kinase family: Atypical lives of typical kinases.

45. IAPs Regulate Distinct Innate Immune Pathways to Co-ordinate the Response to Bacterial Peptidoglycans

46. A regulatory region on RIPK2 is required for XIAP binding and NOD signaling activity.

47. Investigation of the shared gene signatures and molecular mechanisms between obstructive sleep apnea syndrome and asthma.

48. Design, synthesis and evaluation of novel thieno[2,3d]pyrimidine derivatives as potent and specific RIPK2 inhibitors.

49. Receptor-Interacting Serine/Threonine-Protein Kinase-2 as a Potential Prognostic Factor in Colorectal Cancer

50. NOD Signaling and Cell Death

Catalog

Books, media, physical & digital resources